Keywords: alizyme, successfully, completes, phase, program, atl-962, uk

Alizyme successfully completes Phase I program for ATL-962

Article | 24 December 2001

Print This

Alizyme of the UK has successfully completed a Phase I clinicaldevelopment program of its anti-obesity drug ATL-962, following the completion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in